AFB Susceptibility MGIT (13 Drugs Panel)

This test evaluates the resistance of Mycobacterium tuberculosis to 13 different drugs. It is essential for guiding treatment in multi-drug resistant tuberculosis.

Also known asAfb Susceptibility - (13 Drugs Panel) Afb Susceptibility - (13 Drugs Panel)

Available via

Home Collection, Lab Visit

Contains

20 parameters

Earliest reports in

15 Working Days

Test details

AFB Susceptibility MGIT (13 Drugs Panel) Test in Mangaluru Overview

Preparations

No special preparations needed

Test included
AFB Susceptibility MGIT (13 Drugs Panel) includes 20 parameters

  • Smear

  • Isolate
  • Streptomycin 1 Mcg/ml
  • Isoniazid 0.1 Mcg/ml
  • Rifampicin 1 Mcg/ml
  • Ethambutol 5 Mcg/ml
  • Pyrazinamide 100 Mcg/ml
  • Para-amino Salicylic Acid 4 Mcg/ml
  • Ethionamide 5 Mcg/ml
  • Kanamycin 2.5 Mcg/ml
  • Ofloxacin 2 Mcg/ml
  • Capreomycin 2.5 Mcg/ml
  • Amikacin 1 Mcg/ml
  • Levofloxacin 1.0 Mcg/ml
  • Rifabutin 0.5 Mcg/ml
  • Linezolid (1 Mcg/ml)
  • Clofazimine (1 Mcg/ Ml)
  • Moxifloxacin (0.25 Mcg/ml)
  • Moxifloxacin (1.0 Mcg/ml)
  • Remark
Frequently Asked Questions

Mycobacterium tuberculosis susceptibility to 13 distinct anti-tuberculosis medications is assessed using the AFB Susceptibility MGIT (Mycobacteria Growth Indicator Tube) 13 Drugs test. By detecting drug-resistant microorganisms, this test aids in directing efficient treatment.

To guarantee proper antibiotic treatment, patients with a TB diagnosis or those suspected of having multidrug-resistant TB (MDR-TB) should have this test performed.

In an MGIT system, a sample—typically sputum—is cultivated to identify bacterial growth and assess how well 13 distinct medications suppress it.

If the result is positive, it means that the bacteria are resistant to one or more of the medications that were tested, which means that the treatment plan needs to be modified to incorporate other, more effective antibiotics.

Results guide the choice of antibiotics, ensuring that the most effective drugs are used, thereby reducing the risk of treatment failure or disease progression.

Test code

1464R3

Specimen vol. and vacutainer information
SpecimenVacutainerVolume
CultureOthers1

Specimen stability information

Culture

Collection instructions

DRUG LIST MANDATORY REQUIRED

Specimen rejection criteria

Test run frequency

'

Turn around time

15 Working Days

Performing locations

Department

  • Micro Biology

CPT and Loinc codes

AFB Susceptibility MGIT (13 Drugs Panel)

16000